334 related articles for article (PubMed ID: 25494641)
21. Impact of rotavirus vaccination in Germany: rotavirus surveillance, hospitalization, side effects and comparison of vaccines.
Uhlig U; Kostev K; Schuster V; Koletzko S; Uhlig HH
Pediatr Infect Dis J; 2014 Nov; 33(11):e299-304. PubMed ID: 24911897
[TBL] [Abstract][Full Text] [Related]
22. Disease Burden of Rotavirus Gastroenteritis in Children Residing in Germany: A Retrospective, Hospital-based Surveillance.
Kowalzik F; Zepp F; Hoffmann I; Binder H; Lautz D; van Ewijk R; Knuf M; Tenenbaum T; Laass M; Reuter T; Schulze-Rath R; Marron M
Pediatr Infect Dis J; 2016 Jan; 35(1):97-103. PubMed ID: 26421806
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of the pentavalent rotavirus vaccine, RotaTeq®, in Finnish infants up to 3 years of age: the Finnish Extension Study.
Vesikari T; Karvonen A; Ferrante SA; Ciarlet M
Eur J Pediatr; 2010 Nov; 169(11):1379-86. PubMed ID: 20559656
[TBL] [Abstract][Full Text] [Related]
24. Reduction in gastroenteritis with the use of pentavalent rotavirus vaccine in a primary practice.
Bégué RE; Perrin K
Pediatrics; 2010 Jul; 126(1):e40-5. PubMed ID: 20587671
[TBL] [Abstract][Full Text] [Related]
25. Fifteen years of experience with the oral live-attenuated human rotavirus vaccine: reflections on lessons learned.
Pereira P; Vetter V; Standaert B; Benninghoff B
Expert Rev Vaccines; 2020 Aug; 19(8):755-769. PubMed ID: 32729747
[TBL] [Abstract][Full Text] [Related]
26. Primary care-based surveillance to estimate the proportion of rotavirus gastroenteritis among Latvian children below 5 years of age with acute gastroenteritis.
Tafalla M; Gardovska D; Gopala K; Kozlovska L
Hum Vaccin Immunother; 2019; 15(6):1272-1278. PubMed ID: 30335570
[No Abstract] [Full Text] [Related]
27. Impact and effectiveness of pentavalent rotavirus vaccine in children <5 years of age in Burkina Faso.
Bonkoungou IJO; Aliabadi N; Leshem E; Kam M; Nezien D; Drabo MK; Nikiema M; Ouedraogo B; Medah I; Konaté S; Ouédraogo-Traoré R; Sangaré L; Kam L; Yé D; Ouattara M; Biey JN; Mwenda JM; Tate JE; Parashar UD
Vaccine; 2018 Nov; 36(47):7170-7178. PubMed ID: 29290478
[TBL] [Abstract][Full Text] [Related]
28. First year experience of rotavirus immunisation programme in Finland.
Leino T; Ollgren J; Salo H; Tiihonen P; Kilpi T
Vaccine; 2012 Dec; 31(1):176-82. PubMed ID: 23122991
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness of 2 rotavirus vaccines against rotavirus disease in Taiwanese infants.
Chang WC; Yen C; Wu FT; Huang YC; Lin JS; Huang FC; Yu HT; Chi CL; Lin HY; Tate JE; Parashar UD; Wu HS; Hsiung CA
Pediatr Infect Dis J; 2014 Mar; 33(3):e81-6. PubMed ID: 24569388
[TBL] [Abstract][Full Text] [Related]
30. Do hospital pressures change following rotavirus vaccine introduction? A retrospective database analysis in a large paediatric hospital in the UK.
Heinsbroek E; Hungerford D; Cooke RPD; Chowdhury M; Cargill JS; Bar-Zeev N; French N; Theodorou E; Standaert B; Cunliffe NA
BMJ Open; 2019 May; 9(5):e027739. PubMed ID: 31097487
[TBL] [Abstract][Full Text] [Related]
31. Equity and impact: Ontario's infant rotavirus immunization program five years following implementation. A population-based cohort study.
Wilson SE; Rosella LC; Wang J; Renaud A; Le Saux N; Crowcroft NS; Desai S; Harris T; Bolotin S; Gubbay J; Deeks SL
Vaccine; 2019 Apr; 37(17):2408-2414. PubMed ID: 30765171
[TBL] [Abstract][Full Text] [Related]
32. Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in austrian children.
Paulke-Korinek M; Rendi-Wagner P; Kundi M; Kronik R; Kollaritsch H
Pediatr Infect Dis J; 2010 Apr; 29(4):319-23. PubMed ID: 19935446
[TBL] [Abstract][Full Text] [Related]
33. Changing molecular epidemiology of rotavirus infection after introduction of monovalent rotavirus vaccination in Scotland.
Mukhopadhya I; Murdoch H; Berry S; Hunt A; Iturriza-Gomara M; Smith-Palmer A; Cameron JC; Hold GL
Vaccine; 2017 Jan; 35(1):156-163. PubMed ID: 27876201
[TBL] [Abstract][Full Text] [Related]
34. Impact of Rotavirus Vaccines on Gastroenteritis Hospitalizations in Western Australia: A Time-series Analysis.
Fathima P; Jones MA; Moore HC; Blyth CC; Gibbs RA; Snelling TL
J Epidemiol; 2021 Aug; 31(8):480-486. PubMed ID: 32801278
[TBL] [Abstract][Full Text] [Related]
35. Assessing the introduction of universal rotavirus vaccination in the Netherlands.
Zomer TP; van Duynhoven YT; Mangen MJ; van der Maas NA; Vennema H; Boot H; de Melker HE
Vaccine; 2008 Jul; 26(29-30):3757-64. PubMed ID: 18514975
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of rotavirus pentavalent vaccine under a universal immunization programme in Israel, 2011-2015: a case-control study.
Muhsen K; Anis E; Rubinstein U; Kassem E; Goren S; Shulman LM; Ephros M; Cohen D
Clin Microbiol Infect; 2018 Jan; 24(1):53-59. PubMed ID: 28442435
[TBL] [Abstract][Full Text] [Related]
37. Impact of Rotavirus Vaccination on Diarrheal Hospitalizations in Children Aged <5 Years in Lusaka, Zambia.
Mpabalwani EM; Simwaka CJ; Mwenda JM; Mubanga CP; Monze M; Matapo B; Parashar UD; Tate JE
Clin Infect Dis; 2016 May; 62 Suppl 2():S183-7. PubMed ID: 27059354
[TBL] [Abstract][Full Text] [Related]
38. Rotavirus Infection in the Auckland Region After the Implementation of Universal Infant Rotavirus Vaccination: Impact on Hospitalizations and Laboratory Implications.
McAuliffe GN; Taylor SL; Drinković D; Roberts SA; Wilson EM; Best EJ
Pediatr Infect Dis J; 2018 Jan; 37(1):e1-e5. PubMed ID: 28746261
[TBL] [Abstract][Full Text] [Related]
39. The impact of Rotavirus mass vaccination on hospitalization rates, nosocomial Rotavirus gastroenteritis and secondary blood stream infections.
Zlamy M; Kofler S; Orth D; Würzner R; Heinz-Erian P; Streng A; Prelog M
BMC Infect Dis; 2013 Mar; 13():112. PubMed ID: 23452879
[TBL] [Abstract][Full Text] [Related]
40. Pentavalent rotavirus vaccine (RotaTeq): a review of its use in the prevention of rotavirus gastroenteritis in Europe.
Plosker GL
Drugs; 2010 Jun; 70(9):1165-88. PubMed ID: 20518582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
